Evotec expands its iPSC-based cell therapy platform EVOcells through licensing agreement with panCELLa
(WorldNews Germany)

Evotec expands its iPSC-based cell therapy platform EVOcells through licensing agreement with panCELLa EVOTEC LICENSES PANCELLA`S STATE-OF-THE-ART IPSC TECHNOLOGIES IACT STEALTH CELLTM AND FAILSAFETM FOR USE IN CELL THERAPY ACCESS TO PANCELLA`S TECHNOLOGY HAS THE POTENTIAL TO ENABLE SAFE AND OFF-THE-SHELF CELL THERAPY PRODUCTS AND LIFTS EVOTEC`S IPSC-BASED CELL THERAPY PLATFORM (`EVOcells`) TO THE NEXT LEVEL EVOTEC TAKES MINORITY SHAREHOLDING IN PANCELLA Hamburg, Germany, and Toronto, Canada, 02 April 2020: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) and the innovative biotechnology company panCELLa Inc. announced today that the companies have entered into a...